Poland· PL-100249624
Paclitaxel Kabi
A paclitaxel product containing paclitaxelum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Paclitaxel is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Paclitaxel · ATC L01CD01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paclitaxel costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paclitaxel · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$19.82
- CZ Czechia$0.61
The record
At a glance
URPL (Poland)- Active substance
- Paclitaxelum
- Manufacturer
- Fresenius Kabi Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- L01CD01
- ATC class
- Paclitaxel
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
- gtin05909990874354
- gtin05909990874347
- gtin05909990874361
- gtin05909990874378
- gtin05909990874385
- gtin05909990874392
- gtin05909990874408
- gtin05909990874439
- gtin05909990874446
- gtin05909990874453
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
651 interactions on record for paclitaxel.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paclitaxel · interactions on record
651 records
- 41 severe
- 302 moderate
- 17 minor
- 291 info
Most severe, free to view
- SaquinavirJ05AE01severe
- IndinavirJ05AE02severe
- RitonavirJ05AE03severe
- NelfinavirJ05AE04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paclitaxel in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumPaclidos 6 mg/mlSandoz
- CzechiaPACLITAXEL EBEWEEBEWE Pharma Ges.m.b.H Nfg.KG, Unterach
- FinlandAnzataxNaPro BioTherapeutics Ltd.
- United StatesPaclitaxelTeva Parenteral Medicines, Inc.
- SwedenPacligen 6 mg/ml Koncentrat till infusionsvätska, lösningSandoz A/S
- IrelandPaclitaxel 6 mg/ml concentrate for solution for infusionFresenius Kabi Deutschland GmbH
- NorwayPaclitaxel AccordAccord Healthcare B.V.
- SwitzerlandPaclitaxel Labatec 150 mg/25 ml, solution à diluer pour perfusionLabatec Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Apacross, Bugvi
- Belgium · Apacross, Bugvi
- Bulgaria · Алсикроса, Паклитаксел Акорд
- Cyprus · Paclitaxel Accord, Paclitaxel Hospira
- Czechia · Alsicrosa, Paclitaxel Ebewe
- Germany · Apacross, Axitaxel
- Denmark · Apacross, Bugvi
- Estonia · Paclitaxel Accord, Paclitaxel Ebewe
- Spain · Apacross, Bugvi
- Finland · Apacross, Pacligen
- France · Bugvi, Paclitaxel Ahcl
- United Kingdom (Northern Ireland) · Apacross, Paclitaxel
- Greece · Biotaxel, Paclitaxel Hospira
- Croatia · Abutrax, Alsicrosa
- Hungary · Bugvi, Paclitaxel Accord
- Ireland · Apacross, Paclitaxel
- Iceland · Abraxane, Apexelsin
- Italy · Abutrax, Apacross
- Liechtenstein · Abraxane, Apexelsin
- Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
- Luxembourg · Bugvi, Paclitaxel Accord Healthcare
- Latvia · Paclitaxel Accord, Paclitaxel Kabi
- Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
- Netherlands · Abutrax, Apacross
- Norway · Abraxane, Apacross
- Portugal · Apacross, Paclitaxel Accord
- Romania · Bugvi, Paclitaxel Accord
- Sweden · Apacross, Bugvi
- Slovenia · Alsicrosa, Paclitaxin
- Slovakia · Paclitaxel Accord, Paclitaxel Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/738a4c2b-3f52-45f4-a62a-93aacc340ea5 GET /v1/drugs/738a4c2b-3f52-45f4-a62a-93aacc340ea5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "6 mg/ml",
"packaging": "05909990874354 ¦ Rp ¦ 66896\n5 fiol. 5 ml\n05909990874347 ¦ Rp ¦ 67006\n1 fiol. 5 ml\n05909990874361 ¦ Rp ¦ 67008\n1 fiol. 16,7 ml\n05909990874378 ¦ Rp ¦ 67009\n5 fiol. 16,7 ml\n05909990874385 ¦ Rp ¦ 67010\n1 fiol. 25 ml\n05909990874392 ¦ Rp ¦ 67011\n5 fiol. 25 ml\n05909990874408 ¦ Rp ¦ 67012\n1 fiol. 50 ml\n05909990874439 ¦ Rp ¦ 67013\n5 fiol. 50 ml\n05909990874446 ¦ Rp ¦ 67014\n1 fiol. 100 ml\n05909990874453 ¦ Rp ¦ 67015\n5 fiol. 100 ml",
"substance": "Paclitaxelum 6 mg/ml",
"common_name": "Paclitaxelum",
"pl_product_id": "100249624",
"pozwolenie_nr": "18327",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about paclitaxel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.